Homocysteine
Research stageAlso known as L-2-amino-4-mercaptobutyric acid, L-Homocysteine.
Recent clinical, regulatory, research and industry developments relating to this drug.
N-homocysteinylation of DJ-1 promotes neurodegeneration in Parkinson's disease.
Plasma homocysteine levels and mortality in patients with coronary artery disease.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes3
Journals, researchers & institutions
- Aging cell1
- The New England journal of medicine1
- Assmann G1
- Bao A1
- Chen G1
- Guo T1
- Hu D1
- Huang J1
- Li Y1
- von Eckardstein A1
- Department of Clinical Laboratory1
- Renmin Hospital of Wuhan University1
- Second Affiliated Hospital of Nanchang University1
- TaiKang Center for Life and Medical Sciences1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 2 of the same disease areas as Homocysteine in the shared literature.
Studied across 2 of the same disease areas as Homocysteine in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature